Article

Depressed and a co-morbid condition: More psychotropics prescribed!

Centre for Quality of Care Research (WOK), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
The European journal of general practice (Impact Factor: 1.22). 02/2008; 14(1):10-8. DOI: 10.1080/13814780701855724
Source: PubMed

ABSTRACT

Depression often occurs simultaneously with a variety of somatic, psychiatric, and social conditions. Knowledge about differences in the pharmacological treatment of depressed patients with and without co-morbidity is lacking.
To compare GPs' pharmacological treatment of depressed patients with and without co-morbidity.
Data were extracted from the computerized medical records of 77 general practices participating in the Dutch National Information Network of General Practice (LINH). We used diagnosis and prescription data of newly diagnosed depressed patients aged 18-65 years (n=4372). A mixed-model technique was used for analyzing the medical data.
During the year after diagnosing depression, depressed patients who also suffered from chronic somatic or psychiatric morbidity were prescribed more psychotropics than patients with depression only. Prescription patterns of psychotropic drugs for depressed patients with and without co-morbid social problems differed only during the first 3 months after diagnosis. For the whole 1-year period after diagnosis, the pharmacological treatment of depression in patients with and without co-morbid social problems did not differ.
Our results indicate that chronic somatic or psychiatric co-morbidity in depressed patients leads to higher GP prescription levels of psychotropics, whereas co-morbid social problems do not seem to influence GPs' pharmacological treatment decisions for depression.

Download full-text

Full-text

Available from: Peter F M Verhaak
  • Source
    • "The higher HRQoL in patients with type 2 diabetes with comorbidity in the DMP group may be related to different factors. According to previous studies, structured chronic care may improve medical care for other conditions as well (13,14). This may be a result of both greater motivation on the part of the doctor to provide treatment and more opportunities to do so, as these patients visit the practice regularly. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This study examined the effectiveness of the German diabetes disease management program (DMP) for patients with varying numbers of other medical conditions with respect to their health-related quality of life (HRQoL). A questionnaire, including the HRQoL-measured EQ-5D, was mailed to a random sample of 3,546 patients with type 2 diabetes (59.3% female). The EQ-5D score was analyzed by grouping patients according to those on a DMP and those receiving routine care. The analysis showed that participation in the DMP (P < 0.001), the number of other medical conditions (P < 0.001), and the interaction between the DMP and the number of other conditions (P < 0.05) had a significant impact on the EQ-5D score. Our findings suggest that the number of other medical conditions may have a negative impact on the HRQoL of patients with type 2 diabetes. The results demonstrate that the German DMP for type 2 diabetes may help counterbalance this effect.
    Full-text · Article · Jun 2009 · Diabetes care
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Väitekirja elektroonilisest versioonist puuduvad publikatsioonid. Käesoleva töö põhieesmärgiks oli leida depressiooniga seotud ja seda mõjutavad tegurid perearsti patsientidel. Selleks analüüsisime, millised haigused kaasuvad sagedamini depressiooniga, kuidas depressioon mõjutab patsientide töövõimelisust, millised tegurid on seotud depressiooni kordumisega ning milline on depressiooni ja kehalise aktiivsuse seos. Uurimisgrupi moodustasid 1094 järjestikust perearsti vastuvõtule pöördunud patsienti vanuses 18-75 eluaastat ning depressiooni olemasolu kindlaks tegemiseks kasutasime Rahvusvahelist Diagnostilist Liitintervjuud (CIDI). Töö tulemustest võib järeldada, et depressiooniga haiged külastasid oma perearsti sama sagedusega kui depressioonita haiged, kuid olid oluliselt kauem töövõimatuslehel ja hindasid oma tervist halvemaks. Võrreldes omavahel depressiooniga ja depressioonita patsientide kaasuvate haiguste arvu ja haiguste gruppe, olulisi erinevusi me ei leidnud. Umbes kolmandikul depressiooniga haigetest esines korduva depressiooni episood ühe aasta jooksul. Tegurid, mis seostusid depressiooni kordumisega olid narkootiliste ravimite kasutamine, diskrimineerimine ja väärkohtlemine lapseeas. Enam tähelepanu peaks pöörama patsientidele, kellel esinevad eelpool nimetatud tegurid. Vaatamata sellele, et depressiooniga patsientide kehalise aktiivsuse tase ja nende motivatsioon alustada regulaarse kehalise tegevusega oli madal, parandas regulaarne kehaline aktiivsus uuritavate kehalise võimekuse taset ja meeleolu. Seetõttu võib regulaarset kehalist aktiivsust kasutada depressiooni mõjutamiseks perearsti patsientidel. The general aim of this study was to find out factors that are associated with or influence depression in family practice attendees. Therefore, we attempted to clarify, whether co-morbidity and disability are more prevalent in depressed than in non-depressed patients; to determine factors associated with recurrent depression; and to study physical activity as one possible method used as intervention for depressed patients in family medicine. The study group consisted of consecutive primary care patients (N=1094), aged 18-75 years, who sought consultation from their family doctor. The occurrence of depression was assessed by using the Composite International Diagnostic Interview (CIDI). From the results it could be concluded that depressed patients consulted their family doctor almost as often as non-depressed patients but their working ability was decreased. Also, depressed patients evaluated their health general by as poorer than non-depressed patients. Co-morbidity was prevalent among depressed patients but we did not find any differences in the number and pattern of co-morbid diagnoses between depressed and non-depressed patients. About one-third of the depressed patients had a recurrent episode of major depression one year later. The factors predicting recurrence included drug abuse, discrimination, and childhood abuse. These factors should be taken into account by family doctors when managing patients with depression. Although, the level of physical activity of depressed patients as well as their motivation to exercise regularly were low, regular physical activity increased their fitness and improved their mood. Therefore, regular physical activity could be used as possible intervention for depressed patients in family medicine.
    Preview · Article ·
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Co-morbidity may influence GPs' treatment decisions for patients with anxiety. However, knowledge about differences in the pharmacological treatment of anxiety disorders in patients with and without co-morbidity is lacking. To compare GPs' pharmacological treatment patterns for anxiety in patients with and without co-morbidity. Data were extracted from computerized medical records of 77 general practices participating in the Dutch National Information Network of General Practice (LINH). We used diagnosis and prescription data of patients, aged 18-65 years, with a newly diagnosed anxiety disorder (n=4604). A mixed model technique was used to determine if there was a difference in the pharmacological treatment of anxiety with and without co-morbidity. During the year after diagnosing anxiety, anxious patients who also suffered from chronic somatic morbidity or social problems were prescribed more benzodiazepines (effect size [ES]=0.44, 95% confidence interval [CI]=0.16-0.72 and ES=0.67, 95% CI=0.22-1.25, respectively) but no more antidepressants than patients with anxiety only. Compared to patients with a single diagnosis of anxiety, anxious patients who suffered simultaneously from other psychiatric conditions received twice as many antidepressant prescriptions (ES=2.07, 95% CI=1.89-2.56) as well as twice as many benzodiazepine prescriptions (ES=1.98, 95% CI=1.84-2.60) during the year after diagnosing anxiety. For all subgroups, the prescription rate of benzodiazepines remained high throughout the year after diagnosing anxiety. Our results indicate that psychiatric co-morbidity in anxious patients leads to higher prescription levels of both antidepressants and benzodiazepines. Chronic somatic co-morbidity and co-morbid social problems also lead to higher prescription levels of benzodiazepines, but does not seem to influence GPs' prescribing of antidepressants. The prescription pattern of benzodiazepines was inconsistent with guideline recommendations.
    Full-text · Article · Jan 2008 · Family Practice
Show more